Endometriosis is never just a physical condition. It is a daily negotiation between the body and the mind - a long, winding challenge that shapes how a woman moves, works, loves, and shows up in her life. The pain is real, but so is the emotional weight that comes with it, a burden that often remains invisible even to the people who care most.

When treatment choices narrow, hope often arrives in small, careful steps. That’s how she describes the beginning: a young woman with endometriosis, years into pain that reshaped her days and bent her life around it. Hormonal therapies had left her flat or volatile. Surgery brought two brilliant years of relief—then the familiar ache returned, spreading from pelvis to back and down her legs like a tide she couldn’t turn.

Numbers show endometriosis affects about 190 million (10%) women and girls of reproductive age across the globe. Approximately one in 10 women in the world will develop endometriosis at one point in their lives. In the US, at least 11% of women (over 6.5 million) have endometriosis.

DCA researchers say their findings are "proof in principle" that this treatment approach works. ‘’That was the biggest challenge in the beginning: no industry support, no clinical applications,” explained Dr. Evangelos Michelakis. Nevertheless, with the generous support of potential donors and the work of the scientific community, anything can happen. Watch the short TV report aired previously in Canada.

Today we would like to present you our first article based on Dichloroacetate usage benefits as described in case series. This writing will focus on a middle aged man who managed to cure his IV stage Non-Hodgin lymphoma with the use of DCA.

We would like to show you one of the ways to accurately measure the powder of Sodium Dichloroacetate and how to dissolve it to make a solution as well as other useful tips.

CRC without doubt is one of the most common cancers in the world. Luckily, if caught early - it is quite curable by surgery. Later stages of Colorectal Cancer become more dependent on chemotherapy treatment.

Dr. Akbar Khan the medical director at Medicor Cancer Centre gives an excellent lecture on DCA Therapy based on his experience treating patients with Sodium Dichloroacetate.

Glioblastoma is known to be an aggressive form of brain cancer with high resistance to cell death and poor response to existing healing methods. All of this leaves us keen on exploring new treatment possibilities.

A study of the infamous Doctor Michelakis' found out that the therapeutic efficiency of DCA could be increased if combined with DNA Methylation inhibitors such as Vidaza.

In the past years, Sodium Dichloroacetate has drawn attention as a possible yet simple and cheap treatment to target cancerous tumors.